DelveInsight's“ Minimal Change Disease – Pipeline Insight, 2025 ” outlines the evolving therapeutic landscape, highlighting ...

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated ...

A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated ...

Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced the first patient has been dosed in the Phase 2 clinical trial ...

Dublin, Aug. 05, 2020 (GLOBE NEWSWIRE) -- The "Nephrotic Syndrome Pipeline Research Monitor, 2020 - Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook" report has been ...

Kidney diseases that lead to nephrotic syndrome are characterized by excessive amounts of protein in urine. This phenomenon is usually caused by kidney damage — specifically, damage to podocytes ...

Compared with a cohort free of kidney disease, patients with primary nephrotic syndrome were nearly 20-times more likely to develop kidney failure within 4.5 years of follow-up, research showed ...

Nephrotic syndrome, defined by increased urine protein levels, is associated with kidney disorders, including membranous nephropathy (MN), primary focal segmental glomerulosclerosis (FSGS), and ...

Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics. [1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relapsing ...

The investigators found that those with nephrotic syndrome had significantly higher rates of end-stage kidney disease, with an adjusted hazard ratio (aHR) of 19.63 (95% confidence interval).

Congenital nephrotic syndrome: Evolution of medical management and results of renal transplantation. J Pediatr 105:549–557. Article CAS Google Scholar ...